세계의 새우 질병 진단 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

Shrimp Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,030,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,267,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,956,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 전 세계 새우 질환 진단 시장에 대한 종합적인 보고서를 발표하고 시장 성장 촉진요인, 동향, 기회, 과제 등 주요 시장 역학을 상세하게 분석했습니다. 이 상세한 보고서는 시장 구조와 예측 기간 동안의 성장 가능성에 대해 밝혔습니다.

주요 인사이트

• 새우의 질병 진단 시장 규모(2024년) : 5억 90만 달러
• 예측 시장 규모(2033년) : 8억 2,100만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 5.6%

새우 질환 진단 약물 시장 - 조사 범위

새우 질병 진단 시장은 양식에 필수적인 새우에 영향을 미치는 다양한 질병의 진단 테스트의 개발과 응용에 초점을 맞추었습니다. 이 시장에는 분자진단, 면역 진단, 생화학 시험 등 다양한 진단 방법이 포함됩니다. 주요 성장 촉진요인으로는 세계 새우 수요 증가, 양식 활동 활성화, 지속 가능한 새우 양식의 필요성 등이 있습니다.

시장 성장 촉진요인:

세계 새우 질병 진단 시장의 성장을 견인하는 주요 요인은 몇 가지 있습니다. 소비와 수출 증가로 뒷받침되는 새우의 세계 수요 증가는 큰 요인이 되고 있습니다. 또한 양식업의 생산성과 수익성을 확보하기 위해 새우 개체수를 건전하게 유지할 필요성이 진단 솔루션의 채용을 뒷받침하고 있습니다. 새우 양식업자의 질병 관리와 예방에 대한 의식 증가도 시장 성장을 지원합니다.

시장 성장 억제요인:

새우 질병 진단 시장은 성장 가능성이 있음에도 불구하고 몇 가지 문제에 직면하고 있습니다. 진보된 진단 기술에 드는 비용이 높기 때문에 특히 소규모 농업 종사자의 도입이 제한될 수 있습니다. 게다가 표준화된 테스트 프로토콜의 부족과 사용 가능한 진단 솔루션의 낮은 인지도는 시장 확대를 방해할 수 있습니다. 규제 문제와 새우 질병의 유행이 지역에 따라 다르다는 것은 큰 장벽이 될 수 있습니다.

시장 기회:

새우 질병 진단 시장은 특히 기술의 진보로 큰 성장 기회를 가져왔습니다. PCR 기반 시험과 같은 분자진단의 혁신은 질병의 검출 능력을 향상시킬 것으로 예상됩니다. 진단 회사와 수산 양식의 이해 관계자와의 협업은 기술 혁신을 촉진하고 시장 범위를 확대 할 수 있습니다. 또한 비용 효율적이고 사용하기 쉬운 진단 도구 개발을 위한 R&D 투자가 증가하고 성장 기회가 더욱 넓어지고 있습니다.

이 보고서에서 다루는 주요 질문

• 세계의 새우 질병 진단 시장을 견인하는 주요 요인은?
• 새우 질병 진단의 도입이 가장 진행되고 있는 것은 어느 지역인가, 또 이 성장에 영향을 주고 있는 동향은 무엇인가?
• 진단 기술의 발전은 경쟁 구도에 어떤 영향을 미치는가?
• 새우 질병 진단 시장의 주요 기업은 어딘가, 그리고 시장 위치를 유지하기 위해 어떤 전략을 취하고 있는가?
• 세계의 새우 질환 진단 시장에서의 새로운 동향과 장래성은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 시장의 혁신/개발 동향

제4장 중요 성공 요인

• 제품 채용 분석
• 최근 제품 승인
• 규제 상황
• 상환 시나리오
• 공급망 분석
• Porter's Five Forces 분석
• PESTLE 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 시약 키트
  • 질병별
  • 최종 사용자별
  • 국가별
• 2024년 시장 시나리오

제7장 세계 시장 수요(금액 또는 규모, 100만 달러) 분석

• 과거 시장 매출(100만 달러) 분석, 2019-2023년
• 시장 분류별 현재와 장래 시장 규모(100만 달러)의 분석과 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대 수익 기회

제8장 시약 키트별 세계 시장 분석

• 소개/주요 조사 결과
• 2019-2023년에 있어서의 시약 키트별 시장 규모(100만 달러)의 실적의 분석
• 시약 키트별 현재와 장래 시장 규모(100만 달러) 분석과 예측, 2024-2033년
  • 신속 시험 키트
  • 분석 기반 키트
• 시약 키트별 시장의 매력 분석

제9장 질병별 세계 시장 분석

• 소개/주요 조사 결과
• 2019-2023년에 있어서의 질병별 시장 규모(100만 달러)의 실적의 분석
• 질병별 현재와 장래 시장 규모(100만 달러) 분석과 예측, 2024-2033년
  • WSSV(백반 증후군 바이러스)
  • TSV(타우라 증후군 바이러스)
  • YHV/GAV(노랑머리/길 관련 바이러스)
  • IHHNV(감염성 피하 조직과 조혈기 바이러스)
  • HPV(간췌장 파보바이러스)
  • MBV(모노돈 바큘로바이러스)
  • IMNV(전염성 근괴사 바이러스)
  • NHP-B(괴사성 간췌염 세균)
  • MoV(몰리리안 바이러스)
  • 조기 사망 증후군(EMS)
• 질병별 시장의 매력 분석

제10장 최종 사용자별 세계 시장 분석

• 소개/주요 조사 결과
• 최종 사용자별 시장 규모(100만 달러)의 과거 분석, 2019-2023년
• 최종 사용자별 현재와 장래 시장 규모(100만 달러)의 분석과 예측, 2024-2033년
  • 어업
  • 수산 양식 연구소
  • 해양연구소
  • 교육연구기관
  • 기타
• 최종 사용자별 시장의 매력 분석

제11장 지역별 세계 시장 분석

• 소개/주요 조사 결과
• 2019-2023년에 있어서의 지역별 시장 규모(100만 달러)의 과거 분석
• 지역별 현재와 장래 시장 규모(100만 달러) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제12장 북미 시장 분석

제13장 라틴아메리카 시장 분석

제14장 유럽 시장 분석

제15장 동아시아 시장 분석

제16장 남아시아 시장 분석

제17장 오세아니아 시장

제18장 중동 및 아프리카 시장 분석

제19장 시장 구조 분석

• 기업 Tier별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장현재분석

제20장 경쟁 분석

• 경쟁 대시보드
• 브랜딩 및 프로모션 전략
• 주요 개발 분석
• 경쟁의 상세
  • HiMedia Laboratories
  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • REAGEN LLC
  • FUJIKURA KASEI CO., LTD.
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab-Ind Resource Sdn Bhd.
  • SUREBIO
  • Auro Biotechnologies Pvt. Ltd.

제21장 사용된 전제조건과 약어

제22장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Shrimp Disease Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

• Shrimp Disease Diagnostics Market Size (2024E): US$500.9 million
• Projected Market Value (2033F): US$821 million
• Global Market Growth Rate (CAGR 2024 to 2033): 5.6%

Shrimp Disease Diagnostics Market - Report Scope:

The Shrimp Disease Diagnostics Market focuses on the development and application of diagnostic tests for various diseases affecting shrimp, which are vital to aquaculture. The market encompasses various diagnostic methods, including molecular diagnostics, immunodiagnostics, and biochemical tests. Key growth drivers include the rising global demand for shrimp, increasing aquaculture activities, and the need for sustainable shrimp farming practices.

Market Growth Drivers:

Several key factors are driving the growth of the global Shrimp Disease Diagnostics Market. The increasing global demand for shrimp, fueled by rising consumption and exports, is a significant contributor. Furthermore, the need to maintain healthy shrimp populations to ensure productivity and profitability in aquaculture is pushing the adoption of diagnostic solutions. Increased awareness of disease management and prevention among shrimp farmers also supports market growth.

Market Restraints:

Despite its growth potential, the Shrimp Disease Diagnostics Market faces several challenges. High costs associated with advanced diagnostic technologies can limit their adoption, especially among small-scale farmers. Additionally, a lack of standardized testing protocols and limited awareness of available diagnostic solutions can hinder market expansion. Regulatory challenges and the varying prevalence of shrimp diseases across regions may also pose significant barriers.

Market Opportunities:

The Shrimp Disease Diagnostics Market presents substantial growth opportunities, particularly through advancements in technology. Innovations in molecular diagnostics, such as PCR-based tests, are expected to enhance disease detection capabilities. Collaborations between diagnostic companies and aquaculture stakeholders can drive innovation and expand market reach. Furthermore, increasing investment in research and development to create cost-effective and user-friendly diagnostic tools presents further opportunities for growth.

Key Questions Answered in the Report:

• What are the primary factors driving the global Shrimp Disease Diagnostics Market?
• Which regions are witnessing the highest adoption of shrimp disease diagnostics, and what trends are influencing this growth?
• How are advancements in diagnostic technologies impacting the competitive landscape?
• Who are the leading players in the Shrimp Disease Diagnostics Market, and what strategies are they implementing to maintain their market positions?
• What are the emerging trends and future prospects in the global Shrimp Disease Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Shrimp Disease Diagnostics Market, including companies like IDEXX Laboratories, Neogen Corporation, and Thermo Fisher Scientific, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic solutions and enhancing their distribution networks. Collaborations with aquaculture stakeholders, research institutions, and regulatory bodies are crucial for market penetration and sustained growth. Ensuring compliance with global regulatory standards and addressing the unique needs of shrimp farmers will help these companies maintain a competitive edge and achieve long-term success in the Shrimp Disease Diagnostics Market.

Key Companies Profiled:

• HiMedia Laboratories
• HiMedia Laboratories
• Speedy Assay Sdn Bhd
• REAGEN LLC
• FUJIKURA KASEI CO., LTD.
• GeneReach Biotechnology Corp.
• Thermo Fisher Scientific
• Lab - Ind Resource Sdn Bhd.
• SUREBIO
• Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

• Rapid Testing Kits
• Assay Based Kits

Disease:

• WSSV (White Spot Syndrome Virus)
• TSV (Taura Syndrome Virus)
• YHV/GAV (Yellow Head/Gill Associated Virus)
• IHHNV (Infectious Hypodermal and Hematopoietic Virus)
• HPV (Hepatopancreatic Parvovirus)
• MBV (Monodon Baculovirus)
• IMNV (Infectious Myonecrosis Virus)
• NHP-B (Necrotising Hepatopancreatitis Bacteria)
• MoV (Mourilyan Virus)
• Early Mortality Syndrome (EMS)

End User:

• Fisheries
• Aquaculture Laboratories
• Marine Laboratories
• Education and Research Institutes

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Recent Product Approvals
• 4.3. Regulatory Landscape
• 4.4. Reimbursement Scenario
• 4.5. Supply Chain Analysis
• 4.6. Porter's Analysis
• 4.7. PESTLE Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Animal Diagnostics Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Growing Healthcare Expenditure
  • 5.2.2. Historic and Current Revenue of Key Players
  • 5.2.3. Increasing Adoption of Diagnostic Tools
  • 5.2.4. Rising Incidences of Infectious Diseases
  • 5.2.5. Introduction of New and Advance Reagent Kits and Devices
  • 5.2.6. High Cost of Diagnostic kits
  • 5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
  • 5.2.8. Strategic Collaboration Among Players
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Reagent Kits
  • 6.1.2. By Disease
  • 6.1.3. By End User
  • 6.1.4. By Country
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Reagent Kits

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024-2033
  • 8.3.1. Rapid Testing Kits
  • 8.3.2. Assay Based Kits
• 8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
  • 9.3.1. WSSV (White Spot Syndrome Virus)
  • 9.3.2. TSV (Taura Syndrome Virus)
  • 9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
  • 9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • 9.3.5. HPV (Hepatopancreatic Parvovirus)
  • 9.3.6. MBV (Monodon Baculovirus)
  • 9.3.7. IMNV (Infectious Myonecrosis Virus)
  • 9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
  • 9.3.9. MoV (Mourilyan Virus)
  • 9.3.10. Early Mortality Syndrome (EMS)
• 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
  • 10.3.1. Fisheries
  • 10.3.2. Aquaculture Laboratories
  • 10.3.3. Marine Laboratories
  • 10.3.4. Education and Research Institutes
  • 10.3.5. Others
• 10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East & Africa
• 11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Reagent Kits
  • 12.3.3. By Disease
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Reagent Kits
  • 12.4.3. By Disease
  • 12.4.4. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Market
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Reagent Kits
      • 12.8.1.2.2. By Disease
      • 12.8.1.2.3. By End User
  • 12.8.2. Canada Market
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Reagent Kits
      • 12.8.2.2.2. By Disease
      • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Reagent Kits
  • 13.3.3. By Disease
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Reagent Kits
  • 13.4.3. By Disease
  • 13.4.4. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Mexico Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Reagent Kits
      • 13.8.1.2.2. By Disease
      • 13.8.1.2.3. By End User
  • 13.8.2. Brazil Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Reagent Kits
      • 13.8.2.2.2. By Disease
      • 13.8.2.2.3. By End User
  • 13.8.3. Argentina Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Reagent Kits
      • 13.8.3.2.2. By Disease
      • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Reagent Kits
  • 14.3.3. By Disease
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Reagent Kits
  • 14.4.3. By Disease
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Reagent Kits
      • 14.8.1.2.2. By Disease
      • 14.8.1.2.3. By End User
  • 14.8.2. Italy Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Reagent Kits
      • 14.8.2.2.2. By Disease
      • 14.8.2.2.3. By End User
  • 14.8.3. France Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Reagent Kits
      • 14.8.3.2.2. By Disease
      • 14.8.3.2.3. By End User
  • 14.8.4. U.K. Market Analysis
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.4.2.1. By Reagent Kits
      • 14.8.4.2.2. By Disease
      • 14.8.4.2.3. By End User
  • 14.8.5. Spain Market Analysis
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.5.2.1. By Reagent Kits
      • 14.8.5.2.2. By Disease
      • 14.8.5.2.3. By End User
  • 14.8.6. BENELUX Market Analysis
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.6.2.1. By Reagent Kits
      • 14.8.6.2.2. By Disease
      • 14.8.6.2.3. By End User
  • 14.8.7. Russia Market Analysis
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.7.2.1. By Reagent Kits
      • 14.8.7.2.2. By Disease
      • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Reagent Kits
  • 15.3.3. By Disease
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Reagent Kits
  • 15.4.3. By Disease
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Reagent Kits
      • 15.8.1.2.2. By Disease
      • 15.8.1.2.3. By End User
  • 15.8.2. Japan Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Reagent Kits
      • 15.8.2.2.2. By Disease
      • 15.8.2.2.3. By End User
  • 15.8.3. South Korea Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Reagent Kits
      • 15.8.3.2.2. By Disease
      • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Reagent Kits
  • 16.3.3. By Disease
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Reagent Kits
  • 16.4.2. By Disease
  • 16.4.3. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Reagent Kits
      • 16.8.1.2.2. By Disease
      • 16.8.1.2.3. By End User
  • 16.8.2. Indonesia Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Reagent Kits
      • 16.8.2.2.2. By Disease
      • 16.8.2.2.3. By End User
  • 16.8.3. Malaysia Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Reagent Kits
      • 16.8.3.2.2. By Disease
      • 16.8.3.2.3. By End User
  • 16.8.4. Thailand Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Reagent Kits
      • 16.8.4.2.2. By Disease
      • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Reagent Kits
  • 17.3.3. By Disease
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Reagent Kits
  • 17.4.2. By Disease
  • 17.4.3. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Reagent Kits
      • 17.8.1.2.2. By Disease
      • 17.8.1.2.3. By End User
  • 17.8.2. New Zealand Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Reagent Kits
      • 17.8.2.2.2. By Disease
      • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkiye
    • 18.3.1.3. North Africa
    • 18.3.1.4. South Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Reagent Kits
  • 18.3.3. By Disease
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Reagent Kits
  • 18.4.3. By Disease
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Reagent Kits
      • 18.8.1.2.2. By Disease
      • 18.8.1.2.3. By End User
  • 18.8.2. Turkiye Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Reagent Kits
      • 18.8.2.2.2. By Disease
      • 18.8.2.2.3. By End User
  • 18.8.3. South Africa Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Reagent Kits
      • 18.8.3.2.2. By Disease
      • 18.8.3.2.3. By End User
  • 18.8.4. North Africa Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Reagent Kits
      • 18.8.4.2.2. By Disease
      • 18.8.4.2.3. By End User

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Branding and Promotional Strategies
• 20.3. Key Development Analysis
• 20.4. Competition Deep Dive
  • 20.4.1. HiMedia Laboratories
    • 20.4.1.1. Overview
    • 20.4.1.2. Product Portfolio
    • 20.4.1.3. Sales Footprint
    • 20.4.1.4. Key Financials
    • 20.4.1.5. SWOT Analysis
    • 20.4.1.6. Strategy Overview
      • 20.4.1.6.1. Marketing Strategy
      • 20.4.1.6.2. Product Strategy
      • 20.4.1.6.3. Channel Strategy
  • 20.4.2. HiMedia Laboratories
    • 20.4.2.1. Overview
    • 20.4.2.2. Product Portfolio
    • 20.4.2.3. Sales Footprint
    • 20.4.2.4. Key Financials
    • 20.4.2.5. SWOT Analysis
    • 20.4.2.6. Strategy Overview
      • 20.4.2.6.1. Marketing Strategy
      • 20.4.2.6.2. Product Strategy
      • 20.4.2.6.3. Channel Strategy
  • 20.4.3. Speedy Assay Sdn Bhd
    • 20.4.3.1. Overview
    • 20.4.3.2. Product Portfolio
    • 20.4.3.3. Sales Footprint
    • 20.4.3.4. Key Financials
    • 20.4.3.5. SWOT Analysis
    • 20.4.3.6. Strategy Overview
      • 20.4.3.6.1. Marketing Strategy
      • 20.4.3.6.2. Product Strategy
      • 20.4.3.6.3. Channel Strategy
  • 20.4.4. REAGEN LLC
    • 20.4.4.1. Overview
    • 20.4.4.2. Product Portfolio
    • 20.4.4.3. Sales Footprint
    • 20.4.4.4. Key Financials
    • 20.4.4.5. SWOT Analysis
    • 20.4.4.6. Strategy Overview
      • 20.4.4.6.1. Marketing Strategy
      • 20.4.4.6.2. Product Strategy
      • 20.4.4.6.3. Channel Strategy
  • 20.4.5. FUJIKURA KASEI CO., LTD.
    • 20.4.5.1. Overview
    • 20.4.5.2. Product Portfolio
    • 20.4.5.3. Sales Footprint
    • 20.4.5.4. Key Financials
    • 20.4.5.5. SWOT Analysis
    • 20.4.5.6. Strategy Overview
      • 20.4.5.6.1. Marketing Strategy
      • 20.4.5.6.2. Product Strategy
      • 20.4.5.6.3. Channel Strategy
  • 20.4.6. GeneReach Biotechnology Corp.
    • 20.4.6.1. Overview
    • 20.4.6.2. Product Portfolio
    • 20.4.6.3. Sales Footprint
    • 20.4.6.4. Key Financials
    • 20.4.6.5. SWOT Analysis
    • 20.4.6.6. Strategy Overview
      • 20.4.6.6.1. Marketing Strategy
      • 20.4.6.6.2. Product Strategy
      • 20.4.6.6.3. Channel Strategy
  • 20.4.7. Thermo Fisher Scientific
    • 20.4.7.1. Overview
    • 20.4.7.2. Product Portfolio
    • 20.4.7.3. Sales Footprint
    • 20.4.7.4. Key Financials
    • 20.4.7.5. SWOT Analysis
    • 20.4.7.6. Strategy Overview
      • 20.4.7.6.1. Marketing Strategy
      • 20.4.7.6.2. Product Strategy
      • 20.4.7.6.3. Channel Strategy
  • 20.4.8. Lab - Ind Resource Sdn Bhd.
    • 20.4.8.1. Overview
    • 20.4.8.2. Product Portfolio
    • 20.4.8.3. Sales Footprint
    • 20.4.8.4. Key Financials
    • 20.4.8.5. SWOT Analysis
    • 20.4.8.6. Strategy Overview
      • 20.4.8.6.1. Marketing Strategy
      • 20.4.8.6.2. Product Strategy
      • 20.4.8.6.3. Channel Strategy
  • 20.4.9. SUREBIO
    • 20.4.9.1. Overview
    • 20.4.9.2. Product Portfolio
    • 20.4.9.3. Sales Footprint
    • 20.4.9.4. Key Financials
    • 20.4.9.5. SWOT Analysis
    • 20.4.9.6. Strategy Overview
      • 20.4.9.6.1. Marketing Strategy
      • 20.4.9.6.2. Product Strategy
      • 20.4.9.6.3. Channel Strategy
  • 20.4.10. Auro Biotechnologies Pvt. Ltd.
    • 20.4.10.1. Overview
    • 20.4.10.2. Product Portfolio
    • 20.4.10.3. Sales Footprint
    • 20.4.10.4. Key Financials
    • 20.4.10.5. SWOT Analysis
    • 20.4.10.6. Strategy Overview
      • 20.4.10.6.1. Marketing Strategy
      • 20.4.10.6.2. Product Strategy
      • 20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료